Financials

  • Market Capitalization 342.61 M
  • Employee 81
  • Founded 1999
  • CEO N/A
  • Website www.agenusbio.com
  • Headquarter Delaware, United States
  • FIGI BBG000C8SWQ9
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
1.01
Rapporto prezzo/fatturato
0.81

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
3126
IPSC
Century Therapeutics, Inc. - Common Stock
2.05 USD+0.99%-3.76%0.00%+318.37%371.20 M USD
3170
LYEL
Lyell Immunopharma, Inc. - Common Stock
14.32 USD-1.45%-4.66%+9.73%-40.80%350.91 M USD
3189
DMAC
DiaMedica Therapeutics Inc. - Common Stock
6.35 USD-0.63%-3.79%-1.09%+11.21%342.43 M USD
3194
FHTX
Foghorn Therapeutics Inc. - Common Stock
5.74 USD-4.33%-16.81%+26.15%+40.69%340.87 M USD

Notizie